Definitive Contract HHSN268201400042C

Award Date 9/8/14
Potential Completion Date 3/7/18
Potential Value $1.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92126, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small business. The contract, valued at $150,000.00, is for research and development related to the "TAS::75 0849::TAS" requirement. Ocean Nano TECH LLC is a provider of nanotechnology products and services, including for environmental testing and targeted...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The $149,991 Firm Fixed Price contract supports research and development of biomedical nanotechnology products and services. The contract has a Total Small Business set-aside. According to the information provided, Ocean Nano TECH LLC has also received prior federal grant awards and sub-awards...
The Department of Health and Human Services awarded a $199,993 Small Business Innovation Research (SBIR) Phase I contract to Ocean Nano TECH LLC, a woman-owned small disadvantaged business, for the development of "Target Specific and Drug Loaded Iron Oxide Nanoparticles for Cancer Imaging and Therapy." The contract, with a completion date of March 30, 2010, is a firm-fixed-price definitive contract. Ocean Nano TECH LLC has also received several federal grant awards and sub-awards to...
This is a $1,200,000.00 cost-plus-fixed-fee contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Ocean Nano TECH LLC, a woman-owned small business. The contract is for the development of "target specific and drug loaded iron oxide nanoparticles for cancer imaging and therapy." This is a small business set-aside contract with a completion date of March 31, 2015. Ocean Nano TECH LLC is a provider of...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase II contract to Ocean Nano TECH LLC, a woman-owned small disadvantaged business, for the development of a quantum dot Förster resonance energy transfer (FRET) immunoassay to quantify intramolecular epitopes of analytes in tissue sections. The definitive, firm-fixed price contract has a potential value of $2,000,000.00 and a...
This is a $299,999 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Ocean Nano TECH LLC, a woman-owned small disadvantaged business based in San Diego, California. The contract is for the development of a Quantum Dot Förster Resonance Energy Transfer (FRET) Immunoassay to quantify intramolecular epitopes of analytes in tissue sections, as part of the Small Business Innovation Research (SBIR) program....
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
This federal contract award of $224,973 was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Nanohybrids Inc., a for-profit company. The contract is for the development of target-specific molecular imaging agents to detect high-risk atherosclerotic plaque, under the Small Business Innovation Research (SBIR) program. The contract is a Definitive Contract, Firm Fixed Price type, with a completion date of September 7, 2015. There is no set-aside designation...
This federal contract award was made by the National Cancer Institute to Ocean Nano TECH LLC, a woman-owned small business, to conduct research and development on multi-biomarker imaging using quantum dots for the prediction of HPV-associated cancers. The $1,000,000.00 cost-plus-fixed-fee contract does not have a set-aside designation. Ocean Nano TECH LLC has also received federal grant awards from the National Institutes of Health National Institute of Environmental Health Sciences for $185,847...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a "Multiplex Label-Free Nanowell Technology...

This is a $1,725,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The contract is for the development of targeted molecular imaging agents to detect high-risk atherosclerotic plaque, in combination with existing imaging modalities. Ocean Nano TECH LLC is a nanotechnology company that has also received other federal grants and sub-awards for projects related to environmental testing and targeted cancer therapies.

Generated 11/15/24, 9:17 AM